Global Human Microbiome Sequencing Market Growth (Status and Outlook) 2025-2031

According to this study, the global Human Microbiome Sequencing market size will reach US$ million by 2031.

United States market for Human Microbiome Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Human Microbiome Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Human Microbiome Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Human Microbiome Sequencing players cover Baseclear B.V., Beijing Genomics Institute (BGI) Genomics Co., Ltd, Charles River Laboratories International Inc., Clinical Microbiomics A/S, Eurofins Scientific SE, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Human Microbiome Sequencing Industry Forecast” looks at past sales and reviews total world Human Microbiome Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Human Microbiome Sequencing sales for 2025 through 2031. With Human Microbiome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Microbiome Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Human Microbiome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Human Microbiome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Human Microbiome Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Microbiome Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Microbiome Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Microbiome Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Next-Generation Sequencing
Traditional Sequencing Technologies
Other

Segmentation by Application:
Genome Analysis
Metabolome Analysis
Transcriptome Analysis
Other Omics Analysis

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Baseclear B.V.
Beijing Genomics Institute (BGI) Genomics Co., Ltd
Charles River Laboratories International Inc.
Clinical Microbiomics A/S
Eurofins Scientific SE
GENEWIZ, Inc.
Illumina, Inc.
Novogene Corporation
OraSure Technologies, Inc.
Oxford Nanopore Technologies, Inc.
Pacific Biosciences of California, Inc.
QIAGEN N.V.
Second Genome, Inc.
Thermo Fisher Scientific Inc.
Viome, Inc.
CosmosID
Leucine Rich Bio Pvt. Ltd.
Microba
Microbiome Insights Inc.
Molzym GmbH & Co. KG

Please note: The report will take approximately 2 business days to prepare and deliver. Show more